How Telemedicine is Transforming Healthcare Distribution with Peter Ax, CEO of UpScript Health
September 17, 202400:23:19

How Telemedicine is Transforming Healthcare Distribution with Peter Ax, CEO of UpScript Health

Telemedicine is addressing the shortage of physicians by providing an accessible and efficient channel for healthcare delivery.

In this episode, Peter Ax, CEO of UpScript Health, explains how he’s played a key role in making healthcare more patient-centric by developing a platform that allows patients to receive prescriptions online and have medications delivered directly to their doorsteps. He discusses the challenges of navigating regulatory hurdles and how UpScript reinvented itself to offer direct-to-consumer platforms for pharmaceutical companies. Throughout this interview, Peter emphasizes the importance of patient safety and efficiency and the role of telemedicine in addressing the physician shortage. Focusing on doing the right thing and growing steadily without the pressure of institutional capital, his approach offers valuable insights into the future of healthcare distribution.

Tune in and learn how innovation and a patient-first mindset are reshaping the healthcare industry!


Resources: 

[00:00:02] [SPEAKER_00]: Hey everybody, welcome back to the Outcomes Rocket Founder Stories.

[00:00:07] [SPEAKER_00]: Saul Marquez here and I'm so excited for our guest today.

[00:00:11] [SPEAKER_00]: His name is Peter Axe and he's the founder and CEO of UpScript Health, a direct consumer

[00:00:18] [SPEAKER_00]: telehealth company providing new distribution channels for pharmaceutical and medical

[00:00:24] [SPEAKER_00]: device brands.

[00:00:25] [SPEAKER_00]: As one of the earliest pioneers of the telemedicine industry, UpScript Health was the first

[00:00:31] [SPEAKER_00]: US company to receive regulatory approval to write online prescriptions in 2002 and

[00:00:38] [SPEAKER_00]: they've helped develop much of the industry's regulatory framework over the last two

[00:00:42] [SPEAKER_00]: decades.

[00:00:43] [SPEAKER_00]: As we've seen, healthcare is taking a turn more on the consumer side of things.

[00:00:48] [SPEAKER_00]: As we see companies like Best Buy in the game, the game is changing and Peter has been

[00:00:54] [SPEAKER_00]: changing it since the early 2000s.

[00:00:56] [SPEAKER_00]: So Peter is so great to have you here excited for our interview today.

[00:01:00] [SPEAKER_01]: Thanks, Saul.

[00:01:01] [SPEAKER_01]: The lighting to be here always the light in the talk about UpScript and our story.

[00:01:05] [SPEAKER_01]: So thanks for the opportunity.

[00:01:06] [SPEAKER_00]: The pleasures are as Peter look, we're going to have plenty of time to unpack up script

[00:01:11] [SPEAKER_00]: but before we go there I love to get to know you better for our listeners and viewers

[00:01:15] [SPEAKER_00]: to get to know you better.

[00:01:17] [SPEAKER_00]: What got you into entrepreneurship and why healthcare?

[00:01:21] [SPEAKER_01]: Saul is a great story.

[00:01:23] [SPEAKER_01]: First off, I had a significant education.

[00:01:26] [SPEAKER_01]: I was sort of an education focused kid.

[00:01:28] [SPEAKER_01]: So I went to undergrad, or I finished on graduate with the law school and I finished

[00:01:32] [SPEAKER_01]: law school, I wanted more education.

[00:01:34] [SPEAKER_01]: I went and got an MBA and after that I ended up working on Wall Street and I was a Wall

[00:01:39] [SPEAKER_01]: Street investment banker for almost a decade, a two focused banker, private equity focused

[00:01:45] [SPEAKER_01]: banker.

[00:01:46] [SPEAKER_01]: But what I always felt was missing was understanding how businesses ran and what a business

[00:01:51] [SPEAKER_01]: really was.

[00:01:51] [SPEAKER_01]: I was excellent at funding businesses, found financing a really interesting area to work

[00:01:56] [SPEAKER_01]: in but I wanted to really operate a business someday.

[00:01:59] [SPEAKER_01]: So after about a decade on the street I left and became an entrepreneur and the first

[00:02:04] [SPEAKER_01]: deal I worked on was I consolidated a laundromats around the country brought up a 200

[00:02:09] [SPEAKER_01]: plus stores or built 200 plus stores in 24 cities sold that asset to credit Swiss and what

[00:02:21] [SPEAKER_01]: was it when I bought everything from a coal mine to a refate printed part business.

[00:02:28] [SPEAKER_01]: And somehow I ended up winning an internet pharmacy in 2000 and I acquired internet

[00:02:34] [SPEAKER_01]: pharmacy.

[00:02:35] [SPEAKER_01]: So to really answer your question, I didn't pick healthcare as an industry.

[00:02:40] [SPEAKER_01]: I wanted to initially work in.

[00:02:41] [SPEAKER_01]: I just saw it as an opportunity to make the reader return on investment.

[00:02:46] [SPEAKER_01]: So that's how I made it.

[00:02:47] [SPEAKER_00]: Man, super cool.

[00:02:48] [SPEAKER_00]: I love the history, Peter and you're the finance guy, MD, JD, investment banking,

[00:02:57] [SPEAKER_00]: PE and then you're like man, I gotta get in the trenches.

[00:02:59] [SPEAKER_00]: I gotta do this.

[00:03:02] [SPEAKER_01]: I'm always looking to reinvent myself in certain ways.

[00:03:05] [SPEAKER_01]: It's just built my history because and it's fun.

[00:03:07] [SPEAKER_01]: I even think now about how to reinvent an upspifte about six years ago into a different

[00:03:13] [SPEAKER_01]: type of business.

[00:03:15] [SPEAKER_00]: So you know, this is great.

[00:03:16] [SPEAKER_00]: This is a great thank you by the way.

[00:03:18] [SPEAKER_00]: I respect your hustle and your thirst for knowledge.

[00:03:22] [SPEAKER_00]: And so I want to just like index this, this idea of redoing up script.

[00:03:28] [SPEAKER_00]: But before we go there, so I want to open up that parenthesis for later, I want to ask you

[00:03:33] [SPEAKER_00]: more about up scripts.

[00:03:34] [SPEAKER_00]: You know, for the benefit of all of us, we want to learn about what you do.

[00:03:37] [SPEAKER_00]: So help educate us on what it is.

[00:03:40] [SPEAKER_01]: So what we do is we help form a company's brain medications direct to consumer.

[00:03:45] [SPEAKER_01]: And we do that with our software platform and our telemedicine network that we

[00:03:51] [SPEAKER_01]: that we own and operate.

[00:03:53] [SPEAKER_01]: So what that means is if you go shopping for specific medication, let's say you

[00:03:58] [SPEAKER_01]: suffer from diabetes and you're looking for a particular drug, you'll go to the website

[00:04:02] [SPEAKER_01]: of that branded drug.

[00:04:04] [SPEAKER_01]: And on that website, you will likely find a button that says would you like to speak

[00:04:09] [SPEAKER_01]: to a telehealth provider?

[00:04:10] [SPEAKER_01]: Would you like to see if this medication is right for you?

[00:04:14] [SPEAKER_01]: You click on that button and you're on the up script health platform.

[00:04:18] [SPEAKER_01]: What we do then is we'll have you visit with a telehealth provider.

[00:04:23] [SPEAKER_01]: We'll have you then assuming the provider decides to prescribe the medication, we may

[00:04:28] [SPEAKER_01]: send the medication directly to you.

[00:04:30] [SPEAKER_01]: But we can use another channel of distribution.

[00:04:32] [SPEAKER_01]: But we make it really, we take an entire ecosystem of healthcare and make it into a closed

[00:04:38] [SPEAKER_01]: loop where you can see a provider immediately, decide if something's right for you and

[00:04:44] [SPEAKER_01]: then have it shipped to you right away.

[00:04:46] [SPEAKER_01]: And what we've really done if you want to pack it, we really create a new channel of distribution

[00:04:52] [SPEAKER_01]: for healthcare and making it extremely patient centric.

[00:04:56] [SPEAKER_00]: I love that, Peter.

[00:04:57] [SPEAKER_00]: And I'll tell you, it isn't right now.

[00:04:59] [SPEAKER_00]: And it could be better.

[00:05:01] [SPEAKER_00]: And you know, it sounds like you guys are doing a really great job of making this possible.

[00:05:06] [SPEAKER_00]: So we moved to Puerto Rico and I was trying to get, you know, I did some blood work.

[00:05:12] [SPEAKER_00]: And I was trying to get some medications and it was just the hassle to get it.

[00:05:17] [SPEAKER_00]: And then, you know, being over here is another layer on top of it, you know?

[00:05:20] [SPEAKER_00]: But what you're doing is big.

[00:05:22] [SPEAKER_00]: So back in 2001 when you acquired the online pharmacy, what was it?

[00:05:27] [SPEAKER_00]: And what did you see it as and how is it different than what it is today?

[00:05:31] [SPEAKER_01]: It's really interesting.

[00:05:32] [SPEAKER_01]: So in 2001, and you may not remember back to that, but there were biaggress spam websites

[00:05:39] [SPEAKER_01]: all over the world.

[00:05:41] [SPEAKER_01]: You were constantly being bombarded with biaggress spam website.

[00:05:44] [SPEAKER_01]: And the company that we acquired was selling biaggress on the unit.

[00:05:47] [SPEAKER_01]: It was also selling a couple of other medications.

[00:05:49] [SPEAKER_01]: It really wasn't in the spamming business, but it had built up a pretty substantial

[00:05:53] [SPEAKER_01]: client base.

[00:05:54] [SPEAKER_01]: I acquired the company with a vision that someday you would be speaking with your doctor

[00:06:01] [SPEAKER_01]: on a desktop computer.

[00:06:03] [SPEAKER_01]: In those days, there were no iPhones, by the way.

[00:06:05] [SPEAKER_01]: So I only thought in terms of desktop computers.

[00:06:08] [SPEAKER_01]: So within 24 hours of acquiring his business, I met with regulators and said, look, we

[00:06:13] [SPEAKER_01]: think there's a lot of broader application that just biaggress on the internet.

[00:06:17] [SPEAKER_01]: We think you can deliver a healthcare really can be at the patients here this mechanism.

[00:06:22] [SPEAKER_01]: And so we met with regulators literally right after signing documents to acquire the

[00:06:26] [SPEAKER_01]: company with 20-prowels and other regulators and said, we want to build a model for online

[00:06:31] [SPEAKER_01]: care.

[00:06:32] [SPEAKER_01]: And in a lot of ways, the regulators, they really didn't know what was happening to the

[00:06:37] [SPEAKER_01]: world.

[00:06:37] [SPEAKER_01]: They knew that people were selling drugs on the internet.

[00:06:40] [SPEAKER_01]: They didn't like it.

[00:06:40] [SPEAKER_01]: They wanted to do everything they could to shut it down.

[00:06:43] [SPEAKER_01]: And here we were coming to them and saying, look, we're going to do this for right way.

[00:06:46] [SPEAKER_01]: We want to work with you.

[00:06:48] [SPEAKER_01]: We don't want to work against you.

[00:06:50] [SPEAKER_01]: We want you to help diagnosis to how we build a model.

[00:06:52] [SPEAKER_01]: And that's what we did.

[00:06:53] [SPEAKER_01]: We started with CEDU Utah, which is where the company was based on my body.

[00:06:58] [SPEAKER_01]: And we met with regulators and we opened up the dialogue that took about 14 months for

[00:07:04] [SPEAKER_01]: us to formulate a joint consent order that said, here's the prouders under which you

[00:07:10] [SPEAKER_01]: operate.

[00:07:11] [SPEAKER_01]: This is the software we need to develop.

[00:07:13] [SPEAKER_01]: It needs to be sort of intelligent software that when a patient answers a question,

[00:07:18] [SPEAKER_01]: they need to be ordered to the next question that's relevant based on the previous

[00:07:22] [SPEAKER_01]: questions they've answered.

[00:07:23] [SPEAKER_01]: And so we kind of had to develop some intelligence software.

[00:07:27] [SPEAKER_01]: We had to make the protocol with our doctorate's very specific.

[00:07:30] [SPEAKER_01]: They had to be able to show resumes over our doctorate's patients with no

[00:07:33] [SPEAKER_01]: with their talking to.

[00:07:35] [SPEAKER_01]: There were a lot of parameters that were created in those initial,

[00:07:37] [SPEAKER_01]: in that initial year.

[00:07:39] [SPEAKER_01]: And that became the form of stone of what is up to today with the ability to write

[00:07:44] [SPEAKER_01]: a prescription on the air.

[00:07:45] [SPEAKER_00]: And that's really cool Peter.

[00:07:47] [SPEAKER_00]: So back then, you didn't have the virtual care component of a platform.

[00:07:51] [SPEAKER_00]: It was just distribution.

[00:07:53] [SPEAKER_01]: It was about distribution.

[00:07:54] [SPEAKER_01]: It was about writing a prescription on the internet.

[00:07:56] [SPEAKER_01]: So it was about the internet interaction you have with a healthcare provider that needed

[00:08:02] [SPEAKER_01]: to rise to the standard of care that was typical in the marketplace.

[00:08:06] [SPEAKER_01]: So if a standard of care in the state of Utah was to meet and face to face,

[00:08:11] [SPEAKER_01]: visit with a position, then we needed to be able to do a video transmission in the

[00:08:16] [SPEAKER_01]: state of Utah to meet face to face with the position.

[00:08:19] [SPEAKER_01]: And so forth.

[00:08:19] [SPEAKER_01]: And then after Utah, we went state by state, different states had different requirements

[00:08:24] [SPEAKER_01]: for us.

[00:08:25] [SPEAKER_01]: Someone say, well, you can have a phone call.

[00:08:27] [SPEAKER_01]: Our doctors in our region described simply with phone calls.

[00:08:31] [SPEAKER_01]: So you can have a phone call.

[00:08:32] [SPEAKER_01]: That became another modality, little of a rare care and so on.

[00:08:36] [SPEAKER_01]: And so what ended up happening over about a decade is states sort of subcategory

[00:08:41] [SPEAKER_01]: horizon to three different general categories.

[00:08:44] [SPEAKER_01]: The standard of care was item meant with a video transmission or an audio transmission

[00:08:50] [SPEAKER_01]: or in some cases neither it could be meant with simply a question set being prepared

[00:08:54] [SPEAKER_01]: on the internet and the question set, patient responding to and having the physician review

[00:08:59] [SPEAKER_01]: that not in real time.

[00:09:01] [SPEAKER_01]: So those became the three modalities of care.

[00:09:04] [SPEAKER_00]: That's awesome.

[00:09:05] [SPEAKER_00]: Super interesting approach.

[00:09:07] [SPEAKER_00]: You know, a lot of founders and a lot of business owners, they think about expansion

[00:09:13] [SPEAKER_00]: and sort of where the puck is going.

[00:09:17] [SPEAKER_00]: Some people would even say, they try to direct the puck.

[00:09:21] [SPEAKER_00]: You're directing the puck with what you do.

[00:09:23] [SPEAKER_00]: You've been doing it for years.

[00:09:24] [SPEAKER_00]: How do you balance cash flow, profitability and the money that you invest in the future?

[00:09:31] [SPEAKER_01]: Yeah, great question.

[00:09:32] [SPEAKER_01]: And it looked, the real challenge here is you're working in the healthcare industry

[00:09:35] [SPEAKER_01]: and given in the healthcare industry is the safety of the patient.

[00:09:40] [SPEAKER_01]: So money ever becomes a determining factor ahead of that, your loss.

[00:09:45] [SPEAKER_01]: You lost your soul, you cannot operate a business in healthcare.

[00:09:48] [SPEAKER_01]: You won't have the longevity, you won't get funding ultimately, et cetera.

[00:09:52] [SPEAKER_01]: You have to make patient centric.

[00:09:54] [SPEAKER_01]: And you have to be sure that safety is a winner of everything you do.

[00:09:58] [SPEAKER_01]: And then it's been on mantra and we've never focused on bottom line profits over patient safety,

[00:10:04] [SPEAKER_01]: over patient efficiency, over the patient having a good experience.

[00:10:07] [SPEAKER_01]: And that's when we've operated our business.

[00:10:09] [SPEAKER_01]: Unfortunately, it's worked.

[00:10:10] [SPEAKER_01]: It's we've been over pretty nicely profitable enterprise based on doing the right thing.

[00:10:16] [SPEAKER_01]: Now, we haven't been able to chase the brass ring.

[00:10:19] [SPEAKER_01]: We haven't been able to build a giant market cap by putting drugs out there everywhere

[00:10:24] [SPEAKER_01]: to be seen and generating a profit.

[00:10:28] [SPEAKER_01]: We've seen a lot of companies do that generate a fair amount of value.

[00:10:32] [SPEAKER_01]: That's never been the way we've operated.

[00:10:34] [SPEAKER_01]: We've operated it thoughtfully cautiously.

[00:10:36] [SPEAKER_01]: We've grown slower than a lot of companies would normally like to grow.

[00:10:40] [SPEAKER_01]: But a part of the reason why we're going to do that is we're not funded by institutional capital.

[00:10:45] [SPEAKER_01]: I funded the company originally, I funded it since.

[00:10:48] [SPEAKER_01]: And then we've not really had many institutional investors so there's not been any pressure for an exit.

[00:10:53] [SPEAKER_01]: Not been any pressure for months, this growth.

[00:10:56] [SPEAKER_01]: Over year we grow a little bit, we get better and better of what we do.

[00:10:59] [SPEAKER_01]: And right now we're finding we really owned the market space where it right now because of that.

[00:11:05] [SPEAKER_00]: That's fantastic.

[00:11:06] [SPEAKER_00]: Now I love that.

[00:11:07] [SPEAKER_00]: Thanks for the insightful answer there Peter at the end of the day patient centric.

[00:11:12] [SPEAKER_00]: If we're doing that, the business will be solid and you'll get the type of capital that you're looking for.

[00:11:19] [SPEAKER_00]: Long as you're solving those problems.

[00:11:22] [SPEAKER_00]: And so at the beginning of our interview Peter, you talked about reinventing this next question that I want to ask you.

[00:11:28] [SPEAKER_00]: I want to take it toward the reinventing path you were taking us to.

[00:11:32] [SPEAKER_00]: And that's about your biggest setback.

[00:11:35] [SPEAKER_00]: So talk to us about what that has been with up script and a learning that came out of it.

[00:11:40] [SPEAKER_00]: And maybe that's where the reinvention came from.

[00:11:42] [SPEAKER_00]: Maybe not.

[00:11:44] [SPEAKER_01]: Look there's been a lot of setbacks.

[00:11:46] [SPEAKER_01]: This is not going easy.

[00:11:48] [SPEAKER_01]: Right?

[00:11:48] [SPEAKER_01]: And anyone who any time you see a deal that's like, oh, they became a star overnight.

[00:11:54] [SPEAKER_01]: I don't believe it overnight success.

[00:11:56] [SPEAKER_01]: I really do believe it.

[00:11:57] [SPEAKER_01]: I don't even a lot of years and taking us 20 plus years to get where we are.

[00:12:01] [SPEAKER_01]: So a setbacks have been in the form generally speaking of regulatory and the early days in

[00:12:06] [SPEAKER_01]: generally speaking in the form of regulatory issues.

[00:12:09] [SPEAKER_01]: So we thought we were making great traction and for example the state of Texas 15 years ago.

[00:12:14] [SPEAKER_01]: And we'll behold the attorney general wants to give us a hard time about cleaning

[00:12:18] [SPEAKER_01]: prescriptions on the internet and we're trailed from writing prescriptions in Texas until

[00:12:24] [SPEAKER_01]: we litigate there and ultimately prevail and ultimately we were able to write prescriptions

[00:12:30] [SPEAKER_01]: using our modalities.

[00:12:31] [SPEAKER_01]: Those are setbacks we had throughout the way.

[00:12:34] [SPEAKER_01]: We very states, various regulators who were often not healing from a sense of doing the right

[00:12:40] [SPEAKER_01]: thing for the patient as much as they were very frightened as to what might happen with patients

[00:12:44] [SPEAKER_01]: and they were very frightened of our motivations and other companies' motivations so they immediately

[00:12:48] [SPEAKER_01]: shut the door.

[00:12:49] [SPEAKER_01]: I think we had a number of those checkbacks and that happened over kind of like say the first

[00:12:54] [SPEAKER_01]: 10 or 15 years of our development.

[00:12:56] [SPEAKER_01]: Then what happened is the telemedicine stats used to cold and regulators started to realize

[00:13:01] [SPEAKER_01]: no there's a role for telemedicine and what we had been calling internet pharmacies for years

[00:13:05] [SPEAKER_01]: now became telemedicine pharmacies where telemedicine websites.

[00:13:09] [SPEAKER_01]: And so telemedicine story to have brought adoption so that was solved.

[00:13:13] [SPEAKER_01]: But then what we found ourselves, we were in the business of selling generic medications at a

[00:13:19] [SPEAKER_01]: profit writing prescriptions on the internet and we generated profits from signed these generic

[00:13:23] [SPEAKER_01]: medications.

[00:13:25] [SPEAKER_01]: Well I view that as there was suddenly going to be a lot of competitive forces,

[00:13:31] [SPEAKER_01]: margins would erode it'd be very difficult to operate a business of all you're doing

[00:13:35] [SPEAKER_01]: selling generic goods at a profit.

[00:13:37] [SPEAKER_01]: It's eventually you get to zero large in business and I think companies like Roman and

[00:13:41] [SPEAKER_01]: him, you'll probably speak first and I'm sure they've seen more margin erosion over time

[00:13:47] [SPEAKER_01]: because it's just more work competitive than doing what they're doing.

[00:13:50] [SPEAKER_01]: So what we had to do was then say okay how do we create a business that is defensible

[00:13:55] [SPEAKER_01]: that's proprietary that has moats around it and what does that look like?

[00:14:00] [SPEAKER_01]: And so when you talk about disappointments I'd say the disappointment was the core

[00:14:03] [SPEAKER_01]: business that we were involved in for a decade plus earning really attractive profits and

[00:14:08] [SPEAKER_01]: we really had to pivot.

[00:14:10] [SPEAKER_01]: And that was really a defining moment for us.

[00:14:13] [SPEAKER_01]: And our pivot became let's provide direct consumer platforms for pharmacy brands because the

[00:14:21] [SPEAKER_01]: pharmaceutical manufacturers are going to need to be in this business.

[00:14:24] [SPEAKER_01]: They're going to need to have this channel of distribution of direct to consumer.

[00:14:27] [SPEAKER_01]: They don't know how to do it and from a regulatory standpoint they can't only,

[00:14:30] [SPEAKER_01]: they need a third part of the do it for them.

[00:14:34] [SPEAKER_01]: So let's start making headway and build a platform that pharmaceutical companies will use

[00:14:41] [SPEAKER_01]: for us to go direct to consumer.

[00:14:43] [SPEAKER_01]: And that really, so when you talk about the biggest disappointment I'd say the biggest

[00:14:46] [SPEAKER_01]: of why it is the core we had to shift the core business and pivot into a new business.

[00:14:50] [SPEAKER_01]: And that was about six years ago.

[00:14:52] [SPEAKER_01]: And Peter what was the reason for that?

[00:14:54] [SPEAKER_01]: Why did you have to do it?

[00:14:55] [SPEAKER_01]: What we were feeling was that generic medications being sold online was ultimately going to be

[00:15:01] [SPEAKER_01]: a job-wide in business.

[00:15:02] [SPEAKER_00]: Understood.

[00:15:03] [SPEAKER_00]: Yes, yep.

[00:15:03] [SPEAKER_00]: You made a clear point of that.

[00:15:04] [SPEAKER_00]: Yeah, I got it.

[00:15:05] [SPEAKER_00]: Thanks for clarifying.

[00:15:07] [SPEAKER_00]: So we pivoted and said let's partner with farm and manufacturers.

[00:15:11] [SPEAKER_01]: And that's what we did.

[00:15:13] [SPEAKER_00]: So when we talked about this idea come about like I'm just curious, how did that idea come?

[00:15:17] [SPEAKER_00]: Because that's a very nuanced hypothesis, right?

[00:15:21] [SPEAKER_01]: I wish I could say we were geniuses of K-Welph with it.

[00:15:23] [SPEAKER_01]: Oh, here's what happened.

[00:15:25] [SPEAKER_01]: So it's a huge story.

[00:15:27] [SPEAKER_01]: It was a great idea.

[00:15:29] [SPEAKER_01]: Yeah, watch in pharmaceuticals came to us and a guy named Fred Wilkinson who was very senior

[00:15:34] [SPEAKER_01]: well-known in healthcare industry.

[00:15:36] [SPEAKER_01]: He came to us and he said Peter I've been watching you in regulatory battles, state

[00:15:41] [SPEAKER_01]: house to state house across the country trying to do the right thing.

[00:15:45] [SPEAKER_01]: We have a drug that we want to watch to you exclusively upon the internet.

[00:15:49] [SPEAKER_01]: It's called Ella.

[00:15:50] [SPEAKER_01]: It's an emergency contraceptive product.

[00:15:53] [SPEAKER_01]: It needs to compete with the morning after pill and the only way it can compete

[00:15:57] [SPEAKER_01]: with morning act bills if we make the prescribing pattern really simple.

[00:16:01] [SPEAKER_01]: So we want you to prescribe on the internet.

[00:16:04] [SPEAKER_01]: So in 2010, what did years ago now, Watson Pharmaceutical was as a largest

[00:16:09] [SPEAKER_01]: general, it's manufactured in the world of the time.

[00:16:12] [SPEAKER_01]: Watson came to us and said we want to launch a drug through you.

[00:16:15] [SPEAKER_01]: And that was the aha of all of it.

[00:16:16] [SPEAKER_01]: Right?

[00:16:17] [SPEAKER_01]: We said wow.

[00:16:19] [SPEAKER_01]: This is a business model we like.

[00:16:22] [SPEAKER_00]: I love it.

[00:16:23] [SPEAKER_00]: And by Peter, so what an awesome story, right?

[00:16:25] [SPEAKER_00]: And I've heard this the best way to succeed in business is to be in business and

[00:16:30] [SPEAKER_00]: stay in business.

[00:16:32] [SPEAKER_00]: You did just that.

[00:16:33] [SPEAKER_00]: So did you run into this guy at a conference that he call you or how did that happen?

[00:16:38] [SPEAKER_01]: Call me out of the blue.

[00:16:39] [SPEAKER_01]: And you have to do it.

[00:16:40] [SPEAKER_01]: In those days people called me on the blue was usually a tell me they were going to

[00:16:44] [SPEAKER_01]: sue me because we shouldn't sue you.

[00:16:46] [SPEAKER_01]: You do their stay.

[00:16:47] [SPEAKER_01]: I see.

[00:16:49] [SPEAKER_00]: Oh man, that is insane.

[00:16:52] [SPEAKER_01]: Well, that was a great call.

[00:16:53] [SPEAKER_00]: Oh yeah, you were going to say something.

[00:16:54] [SPEAKER_00]: Go for it.

[00:16:55] [SPEAKER_01]: The extension of that was within days Fred Wilkinson had about 20 people flown out to our

[00:17:01] [SPEAKER_01]: offices in the hospital Arizona.

[00:17:03] [SPEAKER_01]: Our offices were beating up for a company 20 people.

[00:17:06] [SPEAKER_01]: We had to rent office space temporarily to accommodate these 20 plus people flying in

[00:17:11] [SPEAKER_01]: and we sat around for three days and came up with exactly what we were going to build

[00:17:14] [SPEAKER_01]: software wise to be able to sell along line.

[00:17:17] [SPEAKER_01]: Love it man.

[00:17:18] [SPEAKER_00]: Love it.

[00:17:19] [SPEAKER_00]: And then you put it together and you're like, we've got something here.

[00:17:24] [SPEAKER_00]: We've got something here.

[00:17:25] [SPEAKER_01]: We thought this is lightning at a block.

[00:17:27] [SPEAKER_01]: Right?

[00:17:27] [SPEAKER_01]: This is a new channel.

[00:17:28] [SPEAKER_01]: There's going to be a lot of companies that need this.

[00:17:30] [SPEAKER_01]: It was still a couple of years later before we did a second deal.

[00:17:34] [SPEAKER_01]: That way.

[00:17:35] [SPEAKER_01]: And it wasn't a couple of years after them before we did a third one.

[00:17:37] [SPEAKER_01]: But in 22 for example, we did seven partnerships like that in 23.

[00:17:41] [SPEAKER_01]: We did 17 partnerships like that.

[00:17:44] [SPEAKER_00]: And in 24, we'll do over 30 partnerships like Kudos.

[00:17:48] [SPEAKER_00]: I love the exponential growth with that.

[00:17:50] [SPEAKER_00]: And let me ask you something like so you saw that this was viable.

[00:17:54] [SPEAKER_00]: Why did it take?

[00:17:56] [SPEAKER_00]: I mean, I don't know how to say it's so long.

[00:17:59] [SPEAKER_00]: But why wait so long to scale?

[00:18:02] [SPEAKER_01]: Yeah, look, the toughest thing about health care is health care moves at a snail's pace.

[00:18:07] [SPEAKER_01]: Yeah.

[00:18:08] [SPEAKER_01]: I get that.

[00:18:09] [SPEAKER_01]: In a part of it is because it should, because patient safety is a really important

[00:18:13] [SPEAKER_01]: factor here.

[00:18:15] [SPEAKER_01]: A part of it is because it's probably way over-regulated.

[00:18:18] [SPEAKER_01]: I mean, we not only have to deal with regulation of positions on a federal level.

[00:18:22] [SPEAKER_01]: We have to deal with regulations of physicians at a state level, 50 state.

[00:18:27] [SPEAKER_01]: We have to deal with pharmacy rules, 50 state level.

[00:18:31] [SPEAKER_01]: We have to deal with federal pharmacy rules, FDA rules.

[00:18:34] [SPEAKER_01]: We have to deal with corporate practice of medicine rules, anti kickback rules,

[00:18:40] [SPEAKER_01]: on and on.

[00:18:40] [SPEAKER_01]: And regulation and really muddy the water,

[00:18:42] [SPEAKER_01]: for us to make things really slow and tedious.

[00:18:46] [SPEAKER_00]: That's fair.

[00:18:47] [SPEAKER_00]: And sort of like the first few years was probably dedicated to

[00:18:51] [SPEAKER_00]: optimization of processes, really getting things tight.

[00:18:55] [SPEAKER_00]: And then slowly.

[00:18:57] [SPEAKER_00]: Yeah, I love it man.

[00:18:59] [SPEAKER_00]: No, this is so cool.

[00:19:00] [SPEAKER_00]: I love it.

[00:19:00] [SPEAKER_00]: Hey, these things did pair nicely.

[00:19:02] [SPEAKER_00]: I had a feeling they would.

[00:19:06] [SPEAKER_01]: We'd love to be the business today and we're a major channel of distribution

[00:19:10] [SPEAKER_01]: growing every single day with people ordering medications to

[00:19:15] [SPEAKER_01]: wreck from the manufacturer.

[00:19:17] [SPEAKER_00]: Yeah, no, I mean it's brilliant.

[00:19:19] [SPEAKER_00]: And necessary, especially with the shortage of physicians and

[00:19:23] [SPEAKER_00]: you know, inability to get into seesome by it, it gets you what you need.

[00:19:26] [SPEAKER_00]: Like this type of stuff makes a lot of sense.

[00:19:29] [SPEAKER_00]: Peter, this is, go ahead.

[00:19:31] [SPEAKER_01]: Do you think about something else when you go in the doctor's office today

[00:19:35] [SPEAKER_01]: and you want an expensive sort of branded medication,

[00:19:38] [SPEAKER_01]: the doctor generally has to complete a prior authorization

[00:19:41] [SPEAKER_01]: to see if you've got insurance coverage.

[00:19:43] [SPEAKER_01]: Well, as a practical matter, doctors are busy.

[00:19:46] [SPEAKER_01]: Only about 50% of those prior off those actions get completed.

[00:19:49] [SPEAKER_01]: So 50% of the runs that theoretically would get sold don't get sold.

[00:19:54] [SPEAKER_01]: Because in the telemedicine space, we in effect manage the telemedicine

[00:19:58] [SPEAKER_01]: offices.

[00:20:00] [SPEAKER_01]: A hundred percent of all prior off of those nations get processed.

[00:20:03] [SPEAKER_01]: So there's a likely little insurance reimbursement as much higher also.

[00:20:06] [SPEAKER_01]: So everybody wins.

[00:20:07] [SPEAKER_01]: I mean, the patient wins.

[00:20:09] [SPEAKER_01]: The physicians don't have to be bothered with prior off ofizations

[00:20:12] [SPEAKER_01]: in their normal everyday practice. You

[00:20:14] [SPEAKER_01]: can do it if you tell a medicine. It's

[00:20:16] [SPEAKER_01]: just, it's a great winning strategy. Agreed.

[00:20:19] [SPEAKER_00]: And the big

[00:20:19] [SPEAKER_00]: one right now will go away some agglutite, GLP ones

[00:20:23] [SPEAKER_00]: are you guys playing there?

[00:20:25] [SPEAKER_01]: We are to some extent.

[00:20:26] [SPEAKER_01]: We're getting, we're going slowly.

[00:20:29] [SPEAKER_01]: It's a massive marketplace.

[00:20:31] [SPEAKER_00]: Massive.

[00:20:31] [SPEAKER_00]: Massive.

[00:20:32] [SPEAKER_01]: You know, our couple of years ago they were predicting

[00:20:34] [SPEAKER_01]: was a 50 billion dollar market.

[00:20:36] [SPEAKER_01]: Then they predicted it was going to be a hundred billion dollar market.

[00:20:38] [SPEAKER_01]: Today they're predicting it maybe as much as a hundred and fifty billion dollar market.

[00:20:43] [SPEAKER_01]: And the largest run to date before this was about 30 billion.

[00:20:47] [SPEAKER_01]: Was that by Agra?

[00:20:48] [SPEAKER_00]: No, that was Shibira, I believe.

[00:20:51] [SPEAKER_00]: Yeah.

[00:20:51] [SPEAKER_00]: Interesting.

[00:20:53] [SPEAKER_00]: Well, we're living an interesting time folks.

[00:20:55] [SPEAKER_00]: That's for sure.

[00:20:57] [SPEAKER_00]: The times are changing.

[00:20:58] [SPEAKER_00]: If you're not changing with them,

[00:21:00] [SPEAKER_00]: you will get left behind.

[00:21:01] [SPEAKER_00]: And that's why I love talking to entrepreneurs like Peter Axe,

[00:21:07] [SPEAKER_00]: founder and CEO at UPScript.

[00:21:09] [SPEAKER_00]: He's doing incredible work.

[00:21:11] [SPEAKER_00]: And he's blazing the trail.

[00:21:13] [SPEAKER_00]: So Peter, we're here at the end.

[00:21:15] [SPEAKER_00]: I love the keep chatting with you.

[00:21:16] [SPEAKER_00]: Maybe we'll do a part two.

[00:21:18] [SPEAKER_00]: What closing thought would you leave our listeners and viewers with?

[00:21:21] [SPEAKER_00]: And what's the best place they could learn more about you and UPScript?

[00:21:26] [SPEAKER_00]: So first of all, go to LookScrewCalth.com

[00:21:28] [SPEAKER_01]: and you'll learn about how we partner with pharmaceutical companies

[00:21:32] [SPEAKER_01]: of all sorts and even consumer products companies.

[00:21:35] [SPEAKER_01]: If I were going to leave some parting thoughts,

[00:21:37] [SPEAKER_01]: I'd say what I've learned through what is now a pretty long career

[00:21:40] [SPEAKER_01]: and 20 plus years in healthcare industry is you always have to do the right thing.

[00:21:46] [SPEAKER_01]: You do the right thing by your investors, you do the right thing by your partners,

[00:21:51] [SPEAKER_01]: you can consumers and all the rest, all the success just come after that.

[00:21:56] [SPEAKER_01]: If you always stick to doing the right thing,

[00:21:59] [SPEAKER_01]: never focus on short term profits,

[00:22:01] [SPEAKER_01]: never focus on your own benefits,

[00:22:03] [SPEAKER_01]: focus on your reals as benefits and you'll do just great and you have a wonderful life.

[00:22:07] [SPEAKER_00]: That's what I like.

[00:22:08] [SPEAKER_00]: What a great way to close a great reminder for all of us.

[00:22:12] [SPEAKER_00]: Let's do the right thing and everything else will fall in the place.

[00:22:16] [SPEAKER_00]: Peter really have enjoyed our time together.

[00:22:18] [SPEAKER_00]: Thank you so much for being with Outcomes Rocket on our Founder Story series.

[00:22:23] [SPEAKER_01]: Great, thanks so much.

[00:22:24] [SPEAKER_01]: It's been wonderful to be here.